Treating Fungal Infections In Patients With Wounds
- Volume 25 - Issue 1 - January 2012
- 7529 reads
- 0 comments
Dr. Mozena says fungal disease is a constant battle between the nail trying to grow out and the fungus progressing inward. In order to address a dynamic disease, Dr. Mozena says the treatment approach should be equally dynamic.
“We should keep an open mind to new treatment options and encourage the scientific proof of their efficacy,” he says.
Dr. Haverstock is an Assistant Clinical Professor of Surgery and the Chief of the Division of Podiatric Surgery in the Department of Surgery at the University of Calgary. He is the Director of the Diabetic Foot and Limb Preservation Centre in Calgary. Dr. Haverstock is also a Fellow of the American Society of Podiatric Dermatology.
Dr. Markinson is the Chief of Podiatric Medicine and Surgery in the Leni and Peter W. May Department of Orthopedic Surgery at the Mount Sinai School of Medicine in New York, N.Y. He is a Fellow of the American Society of Podiatric Dermatology.
Dr. Mozena is in private practice at the Town Center Foot Clinic in Portland, Ore. He is a Fellow of the American College of Foot and Ankle Surgeons, and is board certified in foot and ankle surgery. He is an Associate of the Western Health Sciences University Podiatric and Surgery Department.
Dr. Suzuki is the Medical Director of the Tower Wound Care Center at the Cedars-Sinai Medical Towers. He is also on the medical staff of the Cedars-Sinai Medical Center in Los Angeles and is a Visiting Professor at the Tokyo Medical and Dental University in Tokyo.
1. Scherer WP, Kinmon K. Dermatophyte test medium culture versus mycology laboratory analysis for suspected onychomycosis. A study of 100 cases in a geriatric population. J Am Podiatr Med Assoc. 2000; 90(9):450-9.
2. Zaias N, Rebell G. The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine. Arch Dermatol. 2004; 140(6):691-695.
3. Crawford F, Hollis S. Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev. 2007; 18(3):CD001434.
4. Iozumi K, Hattori N, Adachi M, et al. Long-term follow-up study of onychomycosis: cure rate and dropout rate with oral antifungal treatments. J Dermatol. 2001; 28(3):128-36.
5. Landsman AS, Robbins AH, Angelini PF, et al. Treatment of mild, moderate and severe onychomycosis using 870- and 930-nm light exposure. J Am Podiatr Med Assoc. 2010; 100(3):166-77.
For further reading, see “Pertinent Insights On Diagnosing And Treating Infected Wounds” in the November 2011 issue of Podiatry Today.